SecBot SecBot
6-K ·Filed Sep 10, 2026

SNN

SMITH & NEPHEW PLC
NEUTRAL
Impact 4/10
Horizonimmediate Processed2mo ago SEC0000950103-26-013744
Notable filing: 6-K
Actionable Insight • Neutral

The refinancing is neutral for SNN equity, it extends debt maturities at a higher coupon but does not alter leverage or cash flow. Monitor the tender offer results for the 2.032% notes due 2030; any material take-up would confirm the liability management strategy. No immediate trading catalyst for SNN common stock.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$27.62
T+0 close · Sep 10, 2026 · via day close
Latest settled
−2.39%
T+20 · $26.96 · next T+60 in 17d
Vs SPY
−4.51%
α at T+20
Latest observation
+13.89%
T+45 · FF3 residual α
  1. T+0 · Sep 10 $27.62entry
  2. T+1 · 2mo ago −0.43%α −1.29% · $27.50
  3. T+5 · 2mo ago +0.58%α +1.08% · $27.78
  4. T+20 · 6w ago −2.39%α −4.51% · $26.96
  5. T+47 · todayOpen
  6. T+60 · in 17d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Smith & Nephew priced $700M of 5.750% Notes due 2036, receiving net proceeds of ~$690.9M. The funds will be used to repurchase up to $250M of its lower-coupon 2.032% Senior Notes due 2030 via a concurrent tender offer, with the remainder for general corporate purposes. This is a debt refinancing that extends maturities at a higher coupon but does not change the company's overall leverage or equity value, a routine capital markets transaction with no material impact on SNN common stock fundamentals.

Key Facts

  • Smith & Nephew priced $700M of 5.750% Notes due 2036.
  • Net proceeds to the company are approximately $690.9M after underwriting discounts.
  • Proceeds will fund the purchase of up to $250M of its outstanding 2.032% Senior Notes due 2030 in a concurrent tender offer, plus fees and expenses.
  • Remaining proceeds will be used for general corporate purposes.
  • The offering is scheduled to close on September 11, 2026.
  • This is a debt refinancing, replacing near-term maturities with longer-dated paper at a higher coupon.

Financial Impact

$700M of new 5.750% notes due 2036 issued; net proceeds ~$690.9M used to refinance up to $250M of 2.032% notes due 2030 and for general corporate purposes. No change in overall leverage or equity value.

debtinterest expense

Risk Factors

  • Higher interest expense on the new 5.750% notes vs. the 2.032% notes being tendered, though the amount tendered is capped at $250M.
  • Execution risk on the tender offer and bond issuance closing on September 11, 2026.

Market Snapshot

Exchange
OTC
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
46% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0000950103-26-013744
Document: 0000950103-26-013744-index-headers.html0000950103-26-013744
Document: 0000950103-26-013744-index.html0000950103-26-013744
Document: 0000950103-26-013744.txt0000950103-26-013744

Track record

42 reports on SNN

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +8.02% at T+20 after the Jun 30, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 12, 20264d ago 6-K Neutral 1/10 Entry $31.00 Now $30.97 −0.10% settles Nov 19
  2. Nov 4, 202612d ago 6-K Bearish 6/10 No price data
  3. Nov 4, 202612d ago 6-K Bearish 6/10 Entry $32.46 to $31.04 Now $30.97 +4.59% ▲ +4.37% +3.46% vs SPY
  4. Nov 2, 202614d ago 6-K Neutral 4/10 Entry $30.24 to $31.05 Now $30.97 +2.41% ▲ +2.68% +2.60% vs SPY
  5. Oct 22, 202625d ago 6-K Neutral 2/10 Entry $30.88 to $30.22 Now $30.97 +0.29% ▼ −2.14% −2.84% vs SPY
  6. Oct 8, 20265w ago 6-K Neutral 2/10 Entry $26.96 to $29.09 Now $30.97 +14.87% ▲ +7.90% +8.18% vs SPY
  7. Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
  8. Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
  9. Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
  10. Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
Showing 10 of 42

US Market Status

Market Closed · Opens Wed (11h 25m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 10, 2026